DARRAH COOPER: Open Payments
NPI 1376169904 · CORINTH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,201 in 175 payments from 11 companies in 2025. Trend: 2023 $1,776 · 2024 $2,681 · 2025 $3,201
Food & beverage: $3,201
| Company | Payments | Amount |
|---|---|---|
| Electromed, Inc. | 35 | $599 |
| AstraZeneca Pharmaceuticals LP | 20 | $592 |
| GlaxoSmithKline, LLC. | 36 | $576 |
| Verona Pharma, Inc. | 21 | $297 |
| Viatris Specialty LLC | 18 | $281 |
| Insmed, Inc. | 12 | $212 |
| Regeneron Healthcare Solutions, Inc. | 11 | $205 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $187 |
| GENZYME CORPORATION | 7 | $150 |
| Grifols USA, LLC | 3 | $60 |
Products named: SMARTVEST, FASENRA, DUPIXENT, TRELEGY ELLIPTA, Ohtuvayre, YUPELRI, NUCALA, Arikayce.
Industry payments across MS — which companies pay providers there.
